Zylem Biosciences is a preclinical biotechnology startup, pioneering the development of targeted medicines by employing rational design inspired by nature. Our novel platform technology spans a deep pipeline of therapies applicable to diseases and conditions where lipid dysfunction plays a critical role, including cancer, skin disease, and eye disease. Visit our website to find out more.
| Website | https://www.zylembio.com |
| Employees | 6 (2 on RocketReach) |
| Founded | 2018 |
| Address | 1375 W Fulton St, Chicago, Illinois 60607, US |
| Industry | Biotechnology Research |
| Keywords | Preclinical Research, Biotechnology, Drug Development, Targeted Therapies, New Drug Discovery, Pharmaceutical, Biopharmaceutical, Drug Discovery Platform, Rational Drug Design, Platform Technology, Therapeutics, Molecular Medicine, Clinical Development, Precision Medicine, Bio-Inspired Design, Biologics, Medicine, Life Sciences |
| Competitors | Thermo Fisher Scientific, QIAGEN, Illumina, Agilent Technologies, MilliporeSigma, PerkinElmer, Inc., Bio-Rad Laboratories, BD, Novartis, Regeneron +43 more (view full list) |
Looking for a particular Zylem Biosciences employee's phone or email?
Zylem Biosciences Questions
Kaylin McMahon is the Co-Founder and VP of Operations of Zylem Biosciences.
2 people are employed at Zylem Biosciences.
Zylem Biosciences is based in Chicago, Illinois.
Top Zylem Biosciences Employees
-
23
-
Andrea Calvert
Research Scientist at Zylem Biosciences
Chicago, IL, US14
Related Companies
